Results 11 to 20 of about 284,576 (256)

Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection

Scientific Reports, 2023
Mutations at specific hotspots in non-coding regions of ADGRG6, PLEKHS1, WDR74, TBC1D12 and LEPROTL1 frequently occur in bladder cancer (BC). These mutations could function as biomarkers for the non-invasive detection of BC but this remains largely ...
L. Baxter, N. S. Gordon, S. Ott, J. Wang, P. Patel, A. Goel, K. Piechocki, L. Silcock, C. Sale, M. P. Zeegers, K. K. Cheng, N. D. James, The BladderPath trial management group, R. T. Bryan, D. G. Ward   +14 more
doaj   +1 more source

Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast

Oncology and Therapy, 2023
In this plain language podcast, highlights from the European Society for Medical Oncology (ESMO) Congress are discussed for a second year in a row, from the perspective of both a patient advocate and a healthcare professional.
Alex Filicevas, Thomas Powles
doaj   +1 more source

Oncolytic and immunotherapeutic CG0070 adenovirus for high-risk bacillus calmette-guerin unresponsive bladder cancer

Annals of Urologic Oncology, 2021
Introduction To evaluate the response of patients with high-risk bacillus Calmette-Guerin (BCG)–unresponsive non-muscle invasive bladder cancer (NMIBC) who we treated with intravesical CG0070, a conditionally replicating granulocyte macrophage colony ...
Evan Austin, Debra Mobley, Jamaka Tarajkowski, Donald Lamm   +3 more
doaj   +1 more source

International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members

European Urology Open Science, 2023
Background: Grade of non–muscle-invasive bladder cancer (NMIBC) is an important prognostic factor for progression. Currently, two World Health Organization (WHO) classification systems (WHO1973, categories: grade 1–3, and WHO2004 categories: papillary ...
Irene J. Beijert, Liang Cheng, Fredrik Liedberg, Karin Plass, Sean R. Williamson, Paolo Gontero, Maria J. Ribal, Marko Babjuk, Peter C. Black, Ashish M. Kamat, Ferran Algaba, David M. Berman, Arndt Hartmann, Alexandra Masson-Lecomte, Morgan Rouprêt, Antonio Lopez-Beltran, Hemamali Samaratunga, Shahrokh F. Shariat, A. Hugh Mostafid, Murali Varma, Steven Shen, Maximilian Burger, Toyonori Tsuzuki, Joan Palou, Eva M. Compérat, Richard J. Sylvester, Theo H. van der Kwast, Bas W.G. van Rhijn, Michelle R. Downes   +28 more
doaj   +1 more source

Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient Experience

Inquiry: The Journal of Health Care Organization, Provision, and Financing, 2021
Bladder cancer (BC) is the 10 th most common malignancy worldwide and the patient experience is found to be worse than that for patients diagnosed with other cancer types.
Agustina Bessa, Cecilia Bosco, Fidelma Cahill, Beth Russell, Louis Fox, Charlotte Moss, Harriet Wylie, Anna Haire, Saran Green, Deborah Enting, Shamim Khan, Rajesh Nair, Ramesh Thurairaja, Kathryn Chatterton, Suzanne Amery, Nicola Peat, Sue Smith, Stuart Spear, Richard T Bryan, Leila Frodsham, Danny Burke, Jeannie Rigby, Lydia Makaroff, Phil Kelly, Melanie Costin, Christel Häggström, Mieke Van Hemelrijck   +26 more
doaj   +1 more source

The call for a strategic framework to improve cancer literacy in Europe

Archives of Public Health, 2020
Background Health literacy is increasingly being recognized as a widespread public health challenge in Europe. This commentary explores the importance of health literacy amongst cancer patients (ie, cancer literacy) and examines how cancer literacy can ...
Kristine Sørensen, Lydia E. Makaroff, Laurie Myers, Paul Robinson, Geoffrey J. Henning, Cathryn E. Gunther, Alexander E. Roediger   +6 more
doaj   +1 more source

Intrinsic subtypes and bladder cancer metastasis

Asian Journal of Urology, 2016
Recent studies demonstrated that bladder cancers can be grouped into basal and luminal molecular subtypes that possess distinct biological and clinical characteristics.
David J. McConkey, Woonyoung Choi, Andrea Ochoa, Colin P.N. Dinney   +3 more
doaj   +1 more source

Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma

Diagnostics
Background/Objectives: Clear-cell renal cell carcinoma (ccRCC) represents the predominant histologic subtype of renal cancer and poses persistent diagnostic challenges, particularly in the evaluation of small renal masses, where conventional imaging and ...
Daniel A. González-Padilla, Felipe Villacampa-Auba, Jorge Caño-Velasco, José Daniel Subiela, María Rodríguez, Carlos Yánez, Andrés Calva, Vanessa Talavera, Carmina Muñoz, Marcos Torres, Guillermo Barbas, Guillermo Andrés, Daniel Sánchez-Zalabardo, Edgar Fernando Guillén-Valderrama, Bernardino Miñana-López   +14 more
doaj   +1 more source

Bladder Cancer [PDF]

Journal of the National Comprehensive Cancer Network, 2013
Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of ...
Peter E, Clark, Neeraj, Agarwal, Matthew C, Biagioli, Mario A, Eisenberger, Richard E, Greenberg, Harry W, Herr, Brant A, Inman, Deborah A, Kuban, Timothy M, Kuzel, Subodh M, Lele, Jeff, Michalski, Lance C, Pagliaro, Sumanta K, Pal, Anthony, Patterson, Elizabeth R, Plimack, Kamal S, Pohar, Michael P, Porter, Jerome P, Richie, Wade J, Sexton, William U, Shipley, Eric J, Small, Philippe E, Spiess, Donald L, Trump, Geoffrey, Wile, Timothy G, Wilson, Mary, Dwyer, Maria, Ho   +26 more
openaire   +2 more sources

The Value of Negative Urinary Dipstick Tests for Haematuria in Patients Undergoing Surveillance for Low-grade Ta Urothelial Cancer: A Two-stage Prospective Clinical Study in 524 Patients

European Urology Open Science
Background and objective: The risk of first recurrence beyond 5 yr for patients with low-grade (LG) Ta non–muscle-invasive bladder cancer (NMIBC) is low enough to consider discontinuing cystoscopic surveillance at that point.
Chandrarajan Premal Shah, Tanya Lord-McKenzie, Antonios Makris, Matthew Trail, Jennifer Gray, Gordon Smith, Paramananthan Mariappan   +6 more
doaj   +1 more source